Stocks
CRISPR Therapeutics AGCRSP
NASDAQHealthcareBiotechnology$48.75-0.25%
A biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious genetic diseases. Its pipeline includes ex vivo and in vivo programs targeting conditions such as sickle cell disease, beta thalassemia, and oncology indications, with key collaboration...
Market Cap: $4.7B52W Range: $30.04 – $78.48
This page tracks all publicly disclosed congressional trades in CRISPR Therapeutics AG (CRSP), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 3 purchases and 3 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
6
Unique Politicians
3
Buys
3
Sells
3
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-01 | Michael Fq San Nicolas | buy | $1K – $15K |
| 2021-01-21 | Marjorie Taylor Greene | buy | $1K – $15K |